04.24.09
Biolex Therapeutics Researchers Present Locteron® U.S. Phase 2A Hepatitis C Trial Results at EASL Conference
Press Release
Argos Therapeutics Presents Positive Transplantation and Immunosuppression Data for Soluble CD83 at the American Transplant Congress
04.20.09
Troy startup is a “Bright” spot in VC firm’s portfolio
The Business Review
Biolex Therapeutics Commences Phase 2B Trial of Locteron® in Chronic Hepatitis C
04.13.09
Start-up Clarabridge takes the capital and scores
The Washington Post
04.08.09
Alimera Sciences’ Iluvien™ Phase 3 Studies For DME Pass Final DSMB Review Prior To October Readout
KAI Initiates Third Phase 2a Study to Develop KAI-1678 for the Treatment of Neuropathic Pain
04.03.09
KAI Expands KAI-1678 Development Program, Initiating a Phase 2a Study for Neuropathic Pain
03.30.09
LOC-AID Surpasses 120 Million Subscriber Mark for Location Aggregation, Brings Scale to Location-Based Services Delivery
LOC-AID Platform Provides Fortune 1000 and Specialty LBS Firms Single Point of Access to Location Data across Carriers and Devices
